Nancy Byatt to Antidepressive Agents
This is a "connection" page, showing publications Nancy Byatt has written about Antidepressive Agents.
Connection Strength
1.387
-
Byatt N, Freeman MP. Exposure to selective serotonin reuptake inhibitors in late pregnancy increases the risk of persistent pulmonary hypertension of the newborn, but the absolute risk is low. Evid Based Nurs. 2015 Jan; 18(1):15-6.
Score: 0.407
-
Byatt N, Deligiannidis KM, Freeman MP. Antidepressant use in pregnancy: a critical review focused on risks and controversies. Acta Psychiatr Scand. 2013 Feb; 127(2):94-114.
Score: 0.369
-
Boama-Nyarko E, Flahive J, Zimmermann M, Allison JJ, Person S, Moore Simas TA, Byatt N. Examining racial/ethnic inequities in treatment participation among perinatal individuals with depression. Gen Hosp Psychiatry. 2024 May-Jun; 88:23-29.
Score: 0.200
-
Byatt N, Cox L, Moore Simas TA, Kini N, Biebel K, Sankaran P, Swartz HA, Weinreb L. How obstetric settings can help address gaps in psychiatric care for pregnant and postpartum women with bipolar disorder. Arch Womens Ment Health. 2018 10; 21(5):543-551.
Score: 0.133
-
Byatt N, Xiao RS, Dinh KH, Waring ME. Mental health care use in relation to depressive symptoms among pregnant women in the USA. Arch Womens Ment Health. 2016 Feb; 19(1):187-91.
Score: 0.108
-
Deligiannidis KM, Byatt N, Freeman MP. Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring. J Clin Psychopharmacol. 2014 Apr; 34(2):244-55.
Score: 0.101
-
Glezer A, Byatt N, Cook R, Rothschild AJ. Polypharmacy prevalence rates in the treatment of unipolar depression in an outpatient clinic. J Affect Disord. 2009 Sep; 117(1-2):18-23.
Score: 0.070